aldesleukin

Trials studying aldesleukin

• phase2Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancerrecruitingn=159
• phase2A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)active not recruitingn=94
• phase2A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitisactive not recruitingn=396
• phase1TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCCactive not recruitingn=7
• phase2E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancersrecruitingn=20
• phase2E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancersrecruitingn=15
• phase2A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineeringcompletedn=23
• phase2CISH Inactivated TILs in the Treatment of NSCLCwithdrawn